Showing results by author "Fortrea" in All Categories

Exploring the evolving role of imaging in precision oncology. We discuss the latest advancements in molecular imaging and how imaging is transforming patient selection, early response identification, and the design of clinical studies.

This podcast series spotlights innovations in cardiovascular medicine and clinical research. We explore coronary inflammation as a new frontier in risk management, featuring insights on residual risk, landmark trials, and Abcentra’s monoclonal antibody approach. Then we delve into advanced imaging and trial design strategies for targeted therapies, emphasizing precision medicine and the role of novel endpoints in accelerating development. Together, these conversations highlight emerging science, collaborative solutions, and the shift toward personalized cardiovascular care.

In this series, we discuss the evolving landscape of obesity drug development, exploring the science, patient experiences, and clinical trial innovations that are shaping a new era in care. Through candid conversations with advocates like Sarah Le Brocq and expert insights from host Claudia Filozof, the podcast examines obesity as a complex, chronic disease—challenging stigma, highlighting the importance of empathy in healthcare, and advocating for patient-centric approaches in clinical research.

Diabetes Dialogues is a thought-provoking podcast series that dives deep into the science, challenges, and human stories shaping Type 1 diabetes research and care. Each episode brings together leading experts and advocates to explore breakthroughs in cell and gene therapies, the realities of clinical trial access, and the unique needs of both adult and pediatric populations. Through candid conversations, the series highlights how innovation and inclusion must go hand in hand to create a future without T1D, offering practical insights, emerging tools, and a shared vision for transforming ...

This four-part podcast series from Fortrea dives into the cutting edge of neuroscience research and clinical innovation. Hosted by Amber Burg, Therapeutic Delivery Head of Neuroscience and Ophthalmology, each episode brings together industry leaders and Fortrea experts to explore how technology, data, and strategy are reshaping trials for neurological disorders.

This podcast provides deep insights into the evolving landscape of clinical trials, with a strong emphasis on sustainability and innovation. We explore innovative strategies to drive sustainability and discuss the current state of sustainability in clinical trials, industry focus areas, and the impact on patients.

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?